Clinical trial
Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early…
NCT00005884 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00005884 |
|---|---|
| Title | Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer |
| Official title | Chemoprevention of Skin Cancers With DFMO: A Controlled, Randomized Clinical Trial |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-melanomatous Skin Cancer |
| Intervention type | Drug |
| Interventions | eflornithine |
| Primary completion | Dec 1, 2000 |
| First posted | Jul 26, 2004 |
| Last update posted | Dec 13, 2019 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: